Anti-EMMPRIN antibody treatment of head and neck squamous cell carcinoma in an ex-vivo model

Targeting the molecular pathways associated with carcinogenesis remains the greatest opportunity to reduce treatment-related morbidity and mortality. Extracellular matrix metalloproteinase inducer (EMMPRIN), also known as CD147, is a cell surface molecule known to promote tumor growth and angiogenes...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Dean, Nichole Renae, Knowles, Joseph A., Helman, Emily E., Aldridge, Joszi C., Carroll, William R., Magnuson, Jeffery Scott, Clemons, Lisa, Ziober, Barry, Rosenthal, Eben L.
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4052458/
https://ncbi.nlm.nih.gov/pubmed/20700044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0b013e32833d1a11
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares